Valve Regurgitation, Mitral

2

Review clinical trials related to Valve Regurgitation, Mitral. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65

The safety and efficacy of the Mosaic bioprosthetic heart valves for cardiac valve replacement in the aortic position has been well documented throughout the literature. However, few studies assessing structural valve deficiency, patient outcomes and overall product performance in patients under the age of 65 exists for the Mosaic mitral valve bioprosthetic. This study aims to assess valve efficacy, stability, and post operative outcomes in patients who have received the Mosaic mitral valve prothesis at ProMedica Toledo Hospital and were under the age of 65.

Participants needed: 300
Trial details
Age: 18-65Biological sex: AllType: ObservationalSponsor: Michael MorontUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Received the Mosaic Mitral Valve Bioprosthetic at ProMedica Toledo Hospital [+1]

Over the age of 65 [+2]

Status: Not yet recruiting

Prophylactic Suture Line Sealing With NE'X Glue R-eco in Cardiac and Vascular Surgery

This clinical study aims to evaluate the effectiveness and safety of using NE'X Glue R-eco to seal suture lines. The adhesive will be applied to reduce the risk of suture line bleeding in cardiac or vascular repair surgeries, a prosthetic or biologic graft, patch, or allograft. The effectiveness of the adhesive will be assessed after restoring blood flow.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Grena Biomed LimitedUpdated: Apr 9, 2025Locations: 2
Eligibility criteria

Patient ≥ 18 years of age at study entry. [+3]

Patient has a known hypersensitivity, contraindication, or allergic reaction to... [+10]